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A neoclerodane orthoester 
and other new neoclerodane 
diterpenoids from Teucrium 
yemense chemistry and effect 
on secretion of insulin
Mohammad Nur‑e‑Alam1*, Ifat Parveen2, Barrie Wilkinson3, Sarfaraz Ahmed1, 
Rahman M. Hafizur4, Ahmed Bari5, Timothy J. Woodman6, Michael D. Threadgill2,6 & 
Adnan J. Al‑Rehaily1
Teucrium yemense, a medicinal plant commonly grown in Saudi Arabia and Yemen, is traditionally used 
to treat infections, kidney diseases, rheumatism, and diabetes. Extraction of the dried aerial parts 
of the plant with methanol, followed by further extraction with butanol and chromatography, gave 
twenty novel neoclerodanes. Their structures, relative configurations and some conformations were 
determined by MS and 1‑D and 2‑D NMR techniques. Most were fairly conventional but one contained 
an unusual stable orthoester, one had its (C‑16)–(C‑13)–(C‑14)–(C‑15) (tetrahydro)furan unit present as 
a succinic anhydride and one had a rearranged carbon skeleton resulting from ring‑contraction to give 
a central octahydroindene bicyclic core, rather than the usual decalin. Mechanisms are proposed for 
the biosynthetic formation of the orthoester and for the ring‑contraction. Four novel neoclerodanes 
increased the glucose‑triggered release of insulin from isolated murine pancreatic islets by more than 
the standard drug tolbutamide, showing that they are potential leads for the development of new 
anti‑diabetic drugs.
Teucrium is a genus of the Lamiaceae family. Plants in this large genus are perennial herbs, shrubs and subshrubs 
but present many different  appearances1. They are widespread in the Middle East, Southeast Asia, Central and 
South America and countries surrounding the Mediterranean  Sea2. Saudi Arabia hosts six species of Teucrium 
and is thought to be one of the original centres in which these plants  developed3. Various Teucrium species have 
been used traditionally for millennia as diuretic, diaphoretic, antiseptic and antipyretic  agents4. In Saudi Arabia, 
they have been used in folk medicine to treat diabetes but several other therapeutic activities have been reported 
in different  countries4–7. Plants of this genus have been shown to contain diterpenoids, flavonoids, iridoids, tan-
nins, saponins, alkaloids, sterols, coumarins and  glycosides4,8–10. One species, T. yemense Deflers, is a medicinal 
plant grown in Saudi Arabia, where it is used traditionally to treat infections, kidney diseases, rheumatism and 
 diabetes8,11,12. It is a perennial with a woody base with stems 4–20 cm long; the flowers are pink–pale purple. 
Moreover, extracts of a related species, T. polium, have recently been shown to have activity in animal models 
of  diabetes13,14.
We reported previously the isolation and characterisation of six neoclerodanes from an ethyl acetate (EtOAc) 
extract of T. yemense, of which two stimulated the growth of E. coli but none had antimicrobial or anthelmintic 
 activity15. Nine other neoclerodanes had been identified from this plant by Sattar et al. without evaluation of 
their biological  activity9, whereas other neoclerodanes have been isolated from other Teucrium  species16,17. 
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Neoclerodanes have been also characterised from Scutellaria  species18,19 and Linaria  species20, while neoclero-
danes from Salvia have been identified as inhibitors of HSP90 and as κ-opioid receptor  agonists21–24. In the pre-
sent work, we aimed to enlarge our search for bioactive compounds from this species and seek novel structures. 
We disclose the isolation and structures of twenty new neoclerodanes from the butanol (BuOH) extract of T. 
yemense and report that nine examples enhance the insulin-triggered release of insulin from isolated murine 
pancreatic islets, indicating potential anti-diabetic activity.
Materials and methods
General analytical and chromatographic procedures. See SI. All the methods are carried out in 
accordance with relevant guidelines and regulations.
Plant material. Teucrium yemense Deflers was collected in February 2014, from Akabat Al-Abna, Baljurashi, 
Saudi Arabia. The collected material was identified by taxonomist Dr. M. Yusuf, College of Pharmacy, King Saud 
University (KSU), Riyadh, Saudi Arabia. A voucher specimen (# 15292) has been logged at the herbarium of the 
College of Pharmacy, KSU.
Extraction and isolation. The air-dried and coarsely ground powdered aerial parts of T. yemense (1.6 kg) 
were first defatted with hexane and then extracted with MeOH. Evaporation of the solvent from the latter gave a 
sticky dark mass (388.6 g). This was suspended in water and extracted with EtOAc, then BuOH. Evaporation of 
the solvent from the BuOH extract gave a residue (43.0 g). Column chromatography (silica gel, mesh size 230–
400, hexane → EtOAc/hexane (3:1)) afforded 45 fractions. Fifteen fractions were subjected to radial centrifugal 
chromatography (Chromatotron)  (CH2Cl2/MeOH 19:1), followed by reverse-phase HPLC (C18 column) to give 
new compounds 1–20, along with some known compounds. The detailed isolation scheme is shown in the SI as 
Figure S208.
Fatimanol F (1). Colourless gum; IR 3536, 2970, 1761, 1642, 1218  cm−1; 1H NMR, 13C NMR, COSY, HSQC, 
HMBC, see SI; HRESIMS m/z 457 [M +  K]+, 441.1510 [M +  Na]+, 419.1690 [M +  H]+, 401 [M + H—H2O]+; 
HRESIMS m/z 463.1605 [M +  formate]−, 453.1316 [M + 35Cl]−.
Fatimanone B (2). Colourless gum; IR 3478, 2937, 1796, 1712, 1325, 1238  cm−1; 1H NMR, 13C NMR, COSY, 
HSQC, HMBC, see SI; HRESIMS m/z 421.1855 [M +  Na]+.
Fatimanol G (3). White amorphous powder; IR 3513, 2401, 1716, 1533, 1202  cm−1; 1H NMR, 13C NMR, 
COSY, NOESY, HSQC, HMBC, see SI; HRESIMS m/z 409 [M +  H]+, 379.1747 [M + H –  H2C =  O]+; HRESIMS 
m/z 407.1690 [M −  H]−.
Fatimanol H (4). Colourless gum; IR 3616, 3014, 1715, 1701, 1575, 1202  cm−1; 1H NMR, 13C NMR, COSY, 
NOESY, HSQC, HMBC, see SI; HRESIMS m/z 361 [M +  K]+, 383.1113 [M +  Na]+, 361 [M +  H]+.
Fatimanol I (5). Colourless gum; IR 3618, 2034, 1721, 1763, 1715, 1202  cm−1; 1H NMR, 13C NMR, COSY, 
HSQC, HMBC, see SI; HRESIMS (+ ve) m/z 827.2509 [2 M +  Na]+, 425.1197 [M +  Na]+, 403.1378 [M +  H]+.
Fatimanol J (6). Colourless gum; IR 3593, 3132, 1731, 1726, 1704, 1303, 1271  cm−1; 1H NMR, 13C NMR, 
COSY, HSQC, HMBC, see SI; HRESIMS m/z 397.1248 [M +  Na]+, 375.1429.
Fatimanol K (7). Colourless gum; IR 3433, 2971, 1769, 1737, 1221  cm−1; 1H NMR, 13C NMR, COSY, NOESY, 
HSQC, HMBC, see SI; HRESIMS m/z 425.1459 [M −  H]−.
Fatimanol L (8). White amorphous powder; IR 3615, 3062, 1744, 1734, 1695   cm−1; 1H NMR, 13C NMR, 
COSY, NOESY, HSQC, HMBC, see SI; HRESIMS m/z 519.2212 [M +  Na]+.
Fatimanol M (9). Colourless gum; IR 3546, 2965, 1764, 1752, 1708   cm−1; 1H NMR, 13C NMR, COSY, 
NOESY, HSQC, HMBC, see SI; HRESIMS m/z 535.2189 [M +  Na]+, 513.2350 [M +  H]+.
Fatimanol N (10). Colourless gum; IR: 3631, 3114, 1795, 1790, 1689, 1262, 1132  cm−1; 1H NMR, 13C NMR, 
COSY, HSQC, HMBC, see SI; HRESIMS m/z 427.1596 [M +  H]+; HRESIMS (− ve) m/z 425.1452 [M −  H]−.
Fatimanol O (11). Colourless gum; IR 3414, 3002, 1621, 1417, 1348   cm−1; 1H NMR, 13C NMR, COSY, 
NOESY, HSQC, HMBC, see SI.
Fatimanol P (12). Colourless gum; IR 3584, 3414, 1716, 1419, 1351   cm−1; 1H NMR, 13C NMR, COSY, 
NOESY, HSQC, HMBC, see SI; HRESIMS m/z 443.1706 [M +  Na]+, 421.1854 [M +  H]+.
Fatimanol Q (13). Colourless gum; 1H NMR, 13C NMR, 135DEPT, COSY, HSQC, HMBC, see SI; HRESIMS 
m/z 787.3875 [2 M +  Na]+, 729.3844 [2 M + Na—C2H2O2]+, 405.1880 [M +  Na]+, 347.1850 [M + Na –  C2H2O2]+, 
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329.1744 [M + Na—C2H2O2—H2O]+, 311.1639 [M + Na–C2H2O2—2 ×  H2O]+; HRESIMS m/z 427.1970 
[M +  formate]−, 417.1689 [M + 35Cl]−, 381.1920 [M –  H]−.
Fatimanol R (14). Colourless gum; 1H NMR, 13C NMR, 135DEPT, COSY, HSQC, HMBC, see SI; HRESIMS 
m/z 871.4083 [2  M +  Na]+, 447.1985 [M +  Na]+, 425.2167 [M +  H]+; HRESIMS m/z 469.2075 [M +  formate]−, 
459.1795 [M + 35Cl]−.
Fatimanol S (15). Colourless gum; 1H NMR, 13C NMR, 135DEPT, COSY, NOESY, HSQC, HMBC, see 
SI; HRESIMS m/z 779.3248 [2 M +  Na]+, 401.1567 [M +  Na]+, 379.1748 [M +  H]+, 361.1642 [M + H −  H2O]+, 
343.1537 [M + H − 2 ×  H2O]+, 325.1341 [M + H—3 ×  H2O]+; HRESIMS m/z 423.1656 [M +  formate]−, 377.1605 
[M −  H]−.
Fatimanol T (16). Colourless gum; 1H NMR, 13C NMR, 135DEPT, COSY, NOESY, HSQC, HMBC, see 
SI; HRESIMS m/z 779.3250 [2 M +  Na]+, 401.1568 [M +  Na]+, 379.1748 [M +  H]+, 361.1643 [M + H −  H2O]+, 
325.1432 [M + H − 3 ×  H2O]+.
Fatimanol U (17). Colourless gum; 1H NMR, 13C NMR, 135DEPT, COSY, HSQC, HMBC, see SI; HRESIMS 
983.3881 [2 M +  Na]+, 503.1886 [M +  Na]+, 463.1961 [M + H −  H2O]+, 445.1856 [M + H − 2 ×  H2O]+, 403.1750 
[M + H −  H2O −  AcOH]+, 361.1644 [M + H − 2 ×  AcOH]+; HRESIMS m/z 525.1974 [M +  formate]−, 515.1693 
[M + 35Cl]−, 479.1923 [M −  H]−.
Fatimanol V (18). Colourless gum; 1H NMR, 13C NMR, 135DEPT, COSY, HSQC, HMBC, see SI; HRESIMS 
m/z 803.3255 [2 M +  Na]+, 413.1568 [M +  Na]+.
Fatimanol W (19). Colourless wax; 1H NMR, 13C NMR, 135DEPT, HSQC, HMBC, see SI.
Fatimanol X (20). Colourless gum; 1H NMR, 13C NMR, 135DEPT, HSQC, HMBC, see SI.
Results and discussion
The dried aerial parts of the plant were defatted and extracted with methanol (MeOH). This solvent was evapo-
rated and the residue was extracted with EtOAc, then extracted with BuOH. The BuOH extract was separated 
by column chromatography on silica gel. Radial chromatography and HPLC yielded twenty pure compounds 
(Fig. 1). Their structures were elucidated using 1D and 2D nuclear magnetic resonance (NMR) and high-res-
olution electrospray ionisation mass spectrometry (HRESIMS) data. Their absolute configurations cannot be 
confirmed from these data but are assumed on the basis of precedent for related  compounds9,25,26.
Compound 1. HRESIMS showed pseudomolecular ions at m/z 457 [M +  K]+, m/z 441.1509 [M +  Na]+ (calc 
441.1525) and m/z 419.1690 [M +  H]+ (calc 419.1706), for the formula  C22H26O8. The ion at m/z 401 [M + H 
—  H2O]+ indicated a hydroxy group. Negative pseudomolecular ions were seen at m/z 463.1605 [M +  formate]− 
(calc 463.1605) and m/z 453.1316 [M + 35Cl]− (calc 453.1316). The 13C NMR spectrum (Table S1, Supplementary 
Information (SI)) showed 22 discrete resonances: 2 ×  CH3, 6 ×  CH2, 7 × CH, 7 ×  Cq. The core structure was shown 
to be a decalin and related to the neoclerodane  diterpenoids9,15,16,25. The infra-red (IR) spectrum showed an OH 
(3536  cm−1) and one γ-lactone carbonyl peak (1761  cm−1).
In the upper part of the structure of 1 (Fig. 1), the aromatic furan was characterised by 1H NMR signals at δ 
6.47 (H-14), δ 7.54 (H-15) and δ 7.61 (H-16) (Table S1, SI). A 1H–1H correlation spectrum (COSY) cross-peak 
linked δ 6.47 (H-14) and δ 7.54 (H-15). Heteronuclear single quantum (HSQC) correlation linked the 1H signals 
to 13C signals at δ 109.1 (C-14), δ 145.6 (C-15) and δ 141.80 (C-16); the signal for C-13 (δ 126.3) was identified by 
a strong 3-bond heteronuclear multi-bond (HMBC) correlation to H-15 and weaker 2-bond correlations to H-14 
and H-16. These signals match well with those observed previously for the furans in fatimanol B, fatimanol D and 
fatimanol E.15 The spiro-lactone was identified through the chemical shift of H-12 (δ 5.46) (cf. signals in fatimanol 
B (δ 5.51) and fatimanol D (δ 5.46)15). HMBC tied this proton signal to each furan 13C signal. COSY correlation 
linked H-12 to the doublet signal at δ 2.49 (2 H) and a 2-bond HMBC correlation C-11 at δ 41. Although the two 
H-11 protons are formally diastereotopic, they are coincident for fatimanol  D15 and for 1 (δ 2.49). No 3-bond 
HMBC cross-peaks were seen linking H-12 to the lactone carbonyl (20-C, δ 179.27) or the spiro-carbon (9-C, δ 
49.06), although examination of the MM2-minimised conformation indicated that the corresponding dihedral 
angles (H-12)–(C-12)–(O)–(C-9) and (H-12)–(C-12)–(C-11)–(C-9) are very close to 90°, the coupling constant 
minimum in the Karplus relationship. This model also suggested a rigid trans-decalin conformation for the lower 
part of 1. This conformational and configurational assignment was supported by H-10 resonating as a broad 
doublet at δ 1.89 with 3J = 11.2 Hz for a trans-diaxial coupling with H-1ax. A nuclear Overhauser effect correlation 
spectroscopy (NOESY) experiment ((CD3)2SO solvent) showed a cross-peak between H-18endo (δ 3.69 (δ 3.87 
in  CD3OD)) and H-11 (δ 2.49), thus C-18 (δ 58.3 in  CD3OD) is axial. H-3 was identified by its chemical shift (δ 
4.25) and by HMBC correlations to C-1 (δ 29) and C-4 (δ 87.1). C-3 (δ 71.4) correlated by HSQC to H-3 and 
by HMBC to both 1-H (δ 1.29 and δ 1.60) and to both 2-H (δ 1.60 and δ 2.20). H-3 had a trans-diaxial coupling 
with H-2ax (3J = 10.9 Hz) and was thus axial, making 3-OH equatorial and confirming the conformation of ring A 
as chair. A strong NOESY correlation between 3-H and H-19exo (δ 3.91) showed that  CH2-19 was close in space 
to H-3 and also axial. With H-10 and  CH2-19 both axial, the decalin must be trans-fused.  CH3-17 resonated as 
expected as a doublet at δ 1.08 (1H) and δ 16.1 (13C), linked by HSQC . Strong 3-bond HMBC cross-peaks from 
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 H3-17 to C-9 (δ 49.1) and to C-7 (δ 35.2) and from C-17 to H-7ax (δ 2.27) confirmed this methyl. The 1H signal 
for H-7ax was a dd (2J(H-7ax)−(H-7 eq) = 14.1 Hz, 2J(H-7ax)−(H-8) = 12.9 Hz), showing that H-8 is axial and, therefore, 
 CH3-17 is equatorial. The NOESY experiment ((CD3)2SO) showed a cross-peak between  H3-20 and the H-11 
resonance at δ 2.36 (δ 2.49 in  CD3OD), which is only possible if  CH3-17 is equatorial.
The orthoacetate unit was more challenging to identify. The  CH3 protons gave a singlet at δ 1.43, which is 
inappropriate for an acetate ester, with the 13CH3 signal at δ 23.9. 2-Bond HMBC linked this  CH3 to the orthoe-
ster 13C signal at δ 107.7 / 107.8, which is inappropriate for an ester carbonyl. Thus this 2-carbon unit was not a 
conventional acetate ester, which was consistent with no loss of 60 Da (HOAc) in the MS. The 1H NMR spectrum 
in  (CD3)2SO showed only one OH resonance (HO-3, δ 5.23, with COSY and NOESY correlations with H-3). 
H-18endo (δ 3.87) and H-18exo both formed HMBC cross-peaks with the 13C signal(s) at δ 107.7 / 107.8. Thus one 
Figure 1.  Structures of new neoclerodanes isolated from Teucrium yemense (1–20), of the product 21 of 
pyrolysis of 19-acetylgnaphalin27, and of previously isolated teulepicephin 2215. The numbering of the carbon 
atoms is shown on 1.
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of these signals must have been due to the orthoester carbon (four bonds from  H2-18) and the other due to acetal 
carbon C-5 (three bonds from  H2-18). This confirmed the ring-closure of the (C-6)–(C-5)–(C-4)–(C-18)–(O) 
tetrahydrofuran. C-4 (δ 87.1), C-18 (δ 58.3) and C-19 (δ 74.6) all carry oxygen as shown by their 13C chemical 
shifts. These data are consistent with the orthoacetate structure for 1 (fatimanol F, Fig. 1). Analogue 21, which 
contains the acetal and orthoacetate structures but differs from 1 in lacking HO-3, was  reported27 as a product 
of the pyrolysis of 19-acetylgnaphalin.
Compound 2. HRESIMS showed a pseudomolecular ion at m/z 421.1855 [M +  H]+ (calc 421.1862) for the 
formula  C22H28O8. Fragments were seen at m/z 379 [M + H −  ketene]+ and m/z 361 [M + H −  AcOH]+, showing 
an acetate ester. Twenty-two discrete 13C NMR signals were observed (2 ×  CH3, 6 ×  CH2, 8 × CH, 6 ×  Cq (ester and 
ketone)). IR confirmed these carbonyls, with bands at 1712  cm−1 and 1796  cm−1, respectively. An OH absorbed 
at 3478  cm−1.
The NMR data (Table S1, SI) showed that 2 to be a neoclerodane. The aromatic furan was shown by 1H NMR 
signals at δ 6.41 (H-14), δ 7.43 (H-15) and δ 7.42 (H-16), with HSQC correlations to C-14 (δ 108.8), C-15 (δ 
143.8) and C-16 (δ 139.6), respectively. The C-13 signal (δ 124.8) was identified by HMBC correlations with 
H-14, H-15, and H-16. C-13, C-14, and C-16 showed HMBC cross-peaks with a double doublet (dd) aliphatic 
proton signal at δ 5.25 (H-12). HSQC correlated this with C-12 (δ 71.2). The corresponding signal for H-12 in 
the lactone 1 is downfield at δ 5.46, whereas H-12 in the alcohol 3 resonates upfield at δ 4.85. These comparisons 
suggest that the electron-density at H-12 in 2 is intermediate between that in the lactone 1 and the alcohol 3 and 
is consistent with the hemiacetal/lactol structure in 2. A strong 3-bond HMBC cross-peak linked C-12 with the 
hemiacetal H-20 singlet at δ 5.54. HSQC identified C-20 (δ 99.7). The lactol was completed by identification of 
both H-11 signals (δ 1.93 dd, δ 2.34 dd) by HBMC correlations with C-20, location of C-12 (δ 44.2) by HSQC 
correlation with H-12 and characterisation of the quaternary spiro carbon C-9 (δ 53.6) by HMBC correlations 
with H-12 and H-20. COSY linked both H-11 and H-12. In the lower part, the OH group was located at C-3 
through the chemical shifts of H-3 (δ 4.11) and C-3 (δ 66.4). H-3 had been identified by HMBC correlation to 
C-5 (δ 63.6) and C-3 had been identified by HMBC correlation to H-1 (δ 2.22 and δ 2.64) and H-2 (δ 1.36 and 
δ 2.22). Observation of two geminally coupled doublets (H-18) at δ 2.81 and δ 3.14 (2J = 5.3 Hz) revealed the 
spiro-oxirane. This was shown to be at C-4 by HMBC from these H-18 protons to C-5 (δ 63.6) and from H-3 to 
C-18 (δ 43.7). C-6 was a ketone, as shown by its chemical shift (δ 206.2) and by HMBC cross-peaks to both H-7 
signals (δ 2.28 and δ 2.72) and a 4-bond HMBC correlation with  CH3-17. Examination of a model of 2 suggested 
that ring B was in a flattened-chair conformation, such that the dihedral angles (C-6)–(C-5)–(C-10)–(H-10) and 
(C-6)–(C-7)–(C-8)–(H-8) were close to 90°, explaining the lack of these 3-bond HMBC interactions. The acetoxy-
methyl  (AcOCH2−) group was defined by  CH3-2′ (δH 2.07, δC 21.1) and the ester carbonyl C-1′ (δ 171.2). HMBC 
cross-peaks between C-1′ and the geminally coupled doublets for  H2-19 (δ 4.72, δ 4.83) confirmed the  AcOCH2-; 
HMBC cross-peaks from  H2-19 to C-6, to quaternary C-5 and to the spiro-oxirane carbon (C-4) demostrated 
that this unit was located at C-5. Relevant 3 J coupling constants showed that rings A and B were shown to be in 
chair conformations. For example, the H-7ax signal (δ 2.72) was a broad triplet with 3J = 2J = 14.6 Hz, indicating 
diaxial and geminal couplings, respectively. H-7 eq (δ 2.28) only showed axial-equatorial and geminal couplings. 
Thus Me-17 is equatorial and H-8 is axial and the chair conformation is confirmed. The boat conformation would 
have shown only eq–eq and eq–ax couplings for 3J(H-7)–(H-8).
The NMR spectra showed, in addition to peaks for this major compound, a full set of peaks for a minor 
component, with similar chemical shifts and multiplicities. This minor set of peaks integrated for ca. 10% of the 
major compound present. As the sample gave only one pure peak on HPLC, we ascribed these peaks to a minor 
diastereoisomer in slow equilibrium with the major diastereoisomer. These are likely to be epimers at the lactol 
hemiacetal C-20. This assignment was supported by the largest differences in chemical shift between the epimers 
being for H-3 (Δδ 0.1 ppm), H-14 (Δδ 0.05 ppm), and  H2-19 (Δδ 0.2), as these four protons are close in space to 
the epimeric C-20. We assign the structure 2 (Fig. 1) to fatimanone B.
Compound 3. Negative-ion HRESIMS showed ions at m/z 407.1690 [M −  H]− (calc 407.1706) for the for-
mula  C21H28O8. Positive-ion HRESIMS revealed a pseudomolecular ion at m/z 409 [M +  H]+ and a fragment at 
m/z 379.1747 [M + H –  H2C =  O]+ (calc 379.1757). Twenty-one discrete 13C NMR signals were observed: 2 ×  CH3, 
6 ×  CH2, 7 × CH, 6 ×  Cq, including a carbonyl (δ 172.5). IR showed bands for OH (3513  cm−1) and one carbonyl 
(1716  cm−1).
The NMR data (Table S1, SI) indicated that 3 was a neoclerodane. The upper part was an aromatic furan, with 
1H NMR signals (Table S1, SI) at δ 6.42 (H-14), δ 7.39 (H-16) and δ 7.40 (H-15). The furan 13C NMR signals were 
at δ 108.4 (C-14), δ 130.1 (C-13), δ 138.6 (C-16) and δ 143.9 (C-15), with appropriate HSQC and HMBC con-
nectivities. The chemical shift of H-12 (δ 4.85) showed that it was not part of a lactone or lactol system, confirmed 
by the lack of a HMBC cross-peak to the signal for carbonyl C-20 (δ 172.5). It did show HMBC cross-peaks to 
C-13, C-14, and C-16. Further HMBC cross-peaks were seen from H-12 to C-11 (δ 35.8 or δ 40.0) and to C-9 
(δ 48.5), linking this upper side-chain to the main decalin. The configuration at C-12 could not be established. 
The bridging lactone was established by HMBC cross-peaks between carbonyl C-20 and  H2-19 (δ 4.45, δ 4.68). 
 H2-19 had been confirmed by each signal being a doublet with only geminal coupling (2J = 12.5 Hz) and by 
HMBC cross-peaks to C-6 (δ 110.0) and to C-4 (δ 84.1). C-19 (δ 66.4) was identified by HSQC to  H2-19 and by 
strong HMBC to H-10 (δ 2.24–2.48 m). The signal at δ 72.8 was assigned to C-3 by HMBC cross-peaks to both 
H-2 (δ 1.4, δ 2.1) and to one of the H-1 signals (δ 2.35). H-3 (δ 3.87) was characterised by a HSQC cross-peak to 
C-3, COSY to both H-2 and HMBC to C-1 (δ 21.9), C-2 (δ 30.3) and C-4 (δ 84.1). H-3 is axial, with large 3Jax-ax 
(11.6 Hz) to H-2ax. The H-1 signal at δ 1.29 is a quartet (J = 13.2 Hz); thus it is H-1ax. NOESY correlations from 
H-3 to one H-19 (δ 4.45) and to H-1ax showed that these are on the same face of the decalin; thus the decalin 
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is trans-fused and that ring A is in the chair conformation. The conformation of ring B is less clear, owing to 
overlap of 1H NMR signals but MM2-minimisation suggested that it may be a flattened boat. Acetal carbon C-6 
was characterised by its chemical shift (δ 110.0) and by HMBC cross-peaks to both H-19. Further HMBC correla-
tions were seen to the doublets at δH 3.90 and δH 4.45, showing that they were due to  H2-18 and demonstrating 
the tetrahydrofuran ring. The acetal at C-6 was identified by observation of an OMe (δH 3.40, δC 48.9), linked 
by HMBC to C-6. These data characterise the structure of 3, fatimanol G (Fig. 1). This structure is identical to 
that of teulepicephin 22, with the exception of the acetal (hemiacetal in 14)15; the spectroscopic features are very 
similar, suggesting a similar conformation.
Compound 4. HRESIMS showed pseudomolecular ion peaks at m/z 383.1113 [M +  Na]+ (calc 383.1107) 
and m/z 384.1148, [M +  Na]+ (calc for 12C1813CH20NaO7, 384.1140), appropriate to the formula  C19H20O7, with 
low-intensity ions at m/z 361 [M +  H]+ and m/z 399 [M +  K]+. The 13C NMR spectrum contained signals for 
19 discrete carbons: 1 ×  CH3, 4 ×  CH2, 7 × CH, 7 ×  Cq (including two C = O). The IR indicated hydroxy groups 
(3614  cm−1) and two carbonyls (1715, 1701  cm−1).
The 1H NMR spectrum (Table S2, SI) contained two very similar sets of signals, in ca. 1:1 ratio, suggesting 
diastereoisomers which interconverted slowly on the 1H NMR timescale. This may indicate a cyclic hemiacetal 
(cf. 2). Detailed assignment of the signals was challenging, as many overlapped between the two stereoisomers. 
Taken together, the NMR data showed that 4 had a neoclerodane core. As for 1–3, the upper part was an aromatic 
furan, with 1H NMR signals at δ 6.49 (H-14), δ 7.55 (H-15) and δ 7.61 (H-16). The signals for H-15 and H-16 
were distinguished by a NOESY cross-peak from the former to H-14. The 13C NMR signals for this ring were 
at δ 124.7 (C-13), δ 107.9 (C-14), δ 139.6 (C-15) and δ 144.3 (C-16), as identified by HSQC and HMBC. The 
spiro-lactone was initially identified by the chemical shift of H-12 (δ 5.59), corresponding to a benzylic ester. This 
showed an HSQC cross-peak to C-12 (δ 72.3) and HMBC cross-peaks to C-13, C-14, C-16, and C-11 (δ 40.2). 
HSQC then identified δ 2.73 dd as being due to one H-11 and the two signals at δ 2.56 and δ 2.57 (both dd, each 
integrating for 0.5 H) as due to the other H-11. The 13C signal at δ 176.4 was shown to be the lactone carbonyl 
C-20 by HMBC to H-11 (δ 2.73), H-8 (δ 2.2), and H-10 (δ 2.85). H-3 (δ 4.41) and C-3 (δ 60.5) had the expected 
downfield chemical shifts arising from the OH. COSY then identified H-2 at δ 1.66 and δ 2.10, with HSQC show-
ing C-2 (δ 21.6). Further COSY cross-peaks then showed the resonances for H-1 at δ 1.64 and δ 2.3. The lower 
fused butenolide became evident through HMBC cross-peaks from H-10 to the alkene  Cq peaks for C-4 (δ 128.5) 
and C-5 (δ 163.0). These were distinguished by their chemical shifts and by observation of HMBC from C-4 to 
H-2 (δ 2.01). The carbonyl C-18 was at δ 170.1. The lactone was completed by C-6 (δ 102.4), which shows HMBC 
correlations with both  H2-7, H-8 and H-10. Interestingly, there is also a weak 4-bond HMBC cross-peak between 
 H3C-17 and C-6. The overlap of many of the 1H NMR signals for the two diastereoisomers precluded detailed 
assignments of the conformations of the decalins. We assign structure 4 (Fig. 1) to this compound, fatimanol H.
Compound 5. HRESIMS showed pseudomolecular ions at m/z 425.1197 [M +  Na]+ (calc 425.1212) and m/z 
403.1378 [M +  H]+ (calc 403.1393), for the formula  C21H22O8. There was also a peak at m/z 827.2509 [2 M +  Na]+ 
(calc 827.2527). The 13C NMR spectrum contained signals for 21 discrete carbons: 2 ×  CH3, 4 ×  CH2, 7 × CH, 
8 ×  Cq. The IR showed absorbances for OH (3618  cm−1) and three carbonyls (1763, 1715, 1701  cm−1). The NMR 
spectra (Table S2, SI) were very similar to those for 4, with the exception of additional methyl signals at δH 2.05 
/ δC 20.9, an additional C = O signal at δC 172.1 and a marked downfield change in the chemical shifts of H-3 (δ 
5.59, Δδ 1.18 ppm) and C-3 (δ 64.65, Δδ 4.16 ppm). These indicate that 5 is the 3-O-acetate ester of 4. The 1H 
NMR spectrum contained only one set of signals, showing that one of the possible hemiacetal diastereoisomers 
had significantly lower energy than the other but it was not possible to determine which from the spectroscopic 
data. The methyl protons (H-2′, δ 2.05) of the acetate showed a strong HMBC to the corresponding ester car-
bonyl (C-1′, δ 170). C-1′ also showed a cross-peak to H-3, confirming the location of the ester. We assign struc-
ture 5 (Fig. 1) to fatimanol I.
Compound 6. Compound 6 was also closely related to 4. Pseudomolecular ions were seen in HRESIMS at 
m/z 397.1248 [M +  Na]+ (calc 397.1263) and m/z 375.1429 [M +  H]+ (calc 375.1444), consistent with the formula 
 C20H22O7. A 13C isotopomer peak was observed at m/z 398.1282 (calc 398.1297). The 13C NMR spectrum showed 
discrete signals for 2 ×  CH3, 4 ×  CH2, 7 × CH and 7 ×  Cq. The 1H and 13C NMR spectra (Table S2, SI) (with 2D 
spectra) were very similar to those for 4, with the addition of signals for  OCH3 (δH 3.19, δC 51.0). These protons 
showed a strong HMBC to the 13C signal for C-6 (δ 150.8), identifying the methoxy group as being part of an 
acetal at this position. These data show that 6 (fatimanol J, Fig. 1) has the structure shown.
Compound 7. HRESIMS contained a pseudomolecular ion at m/z 425.1459, corresponding to [M −  H]− 
(calc 425.1526) for the formula  C20H26O10. The 13C NMR spectrum showed discrete resonances for 20 carbons: 
1 ×  CH3, 6 ×  CH2, 6 × CH, 7 ×  Cq. The IR contained absorbances for two carbonyls (1769  cm−1, 1737  cm−1) and 
OH (3433   cm−1). The NMR data (Table  S2, SI) suggested a neoclerodane core. The upper part contained a 
hydroxyfuranone ring, as in fatimanol  A15. This cyclic acetal was represented by H-14 (δ 7.17), which showed 
an HSQC cross-peak to C-14 (δ 146.6); the downfield shifts of these signals were due to the enone system. From 
H-14, 2-bond HMBC cross-peaks were seen to C-13 (δ 108.1) and to C-15 (δ 99.0) and 3-bond cross-peaks were 
evident to the carbonyl C-16 (δ 172.2) and (weakly owing to the adverse dihedral angle) to C-12 (δ 64.0). H-14 
did not show a COSY cross-peak to the hemiacetal proton H-15 (δ 5.88), owing to the small coupling constant 
consequent to a dihedral angle ca. 90°. HSQC identified H-12 as part of a complex multiplet at δ ca. 4.6. A 
2-bond HMBC from H-12 then led to C-11 (δ 41.3), from which HSQC showed the two signals for H-11 (δ 1.6, 
δ 2.25). From the downfield H-11 signal, HMBC identified the signals for C-9 (δ 50.2), C-10 (δ 43.9) and the 
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lactone carbonyl C-20 (δ 174.6). This lactone was confirmed by HMBC cross-peaks from C-20 to H-19 (δ 4.58, 
δ 4.64) and the latter were linked on to C-4 (δ 85.6), C-5 (δ 49.7) and C-6 (δ 108.2). A 2-bond HMBC correla-
tion from C-4 indicated H-3 (δ 3.83). The latter then gave an HMBC cross-peak to the methylene C-18 (δ 75.6) 
with H-18 (δ 3.97 d (J = 10.4 Hz), δ 4.35 d (J = 10.4 Hz)). The downfield H-19 also gave a 3-bond HMBC with 
C-10, completing the lower lactone ring. H-3 resonated as a dd (J = 11.6, 5.9 Hz), the larger of the two coupling 
constants indicating that this proton is axial. Completing the features of the lower part of the structure, H-18 (δ 
4.35) showed a 3-bond HMBC with the hemiacetal carbon C-6. We assign the structure 7 (Fig. 1) to this com-
pound, fatimanol K.
Compound 8. HRESIMS showed a pseudomolecular ion at m/z 519.2212 [M +  Na]+ (calc 519.2206) for the 
formula  C25H36O10. The 13C NMR spectrum showed 25 discrete resonances: 4 ×  CH3, 8 ×  CH2, 6 × CH, and 7 ×  Cq. 
Bands for OH (3615  cm−1) and three ester / lactone carbonyls (1744, 1734, 1695  cm−1) were seen in the IR. Com-
bined interpretation of the NMR spectra (Table S3, SI) showed that 8 was a neoclerodane. The upper ring was 
a furan-2-one. The acetal proton H-15 resonated as a doublet at δ 5.84, with a small coupling constant (2 Hz) 
to H-14 (δ 7.02) confirmed by COSY. HSQC then identified C-15 (δ 104.6) and C-14 (δ 144.8). The latter was 
appropriate for the β-carbon of an enone. HMBC linked H-15 to C-13 (δ 138.9) and the lactone carbonyl C-16 
(δ 173.3). H-14 and C-16 also showed a cross-peak in HMBC. The IR band at 1695  cm−1 was assigned to this 
α,β-unsaturated ester. The methoxy protons (δ 3.52) showed a HMBC cross-peak to C-15, demonstrating its 
location. HSQC identified the methoxy carbon signal at δ 57.3. HMBC from C-13 to both H-12 (δ 2.15, δ 2.28) 
and to both H-11 (δ 1.4. δ 2.25) confirmed the attachment of the methoxyfuranone ring at C-12. C-11 (δ 34.6) 
and C-12 (δ 19.3) were identified by HSQC. A further HMBC cross-peak from H-11 (δ 1.4) to the 13C signal at δ 
66.5  (CH2) showed that the latter was due to C-20. HSQC confirmed the geminally coupled doublets (δ 3.97 and 
δ 4.03) (J = 12.0 Hz) as due to the two H-20. These were linked by HMBC to the carbonyl 13C signal at δ 172.6 
and thence to the acetate protons at δ 2.06. Both H-20 signals had 3-bond HMBC correlations with C-10 (δ 47) 
and C-20 had HMBC correlation with the signal with H-8 (δ 1.7). H-10 (δ 1.7) and C-8 (δ 35.2 or 35.1) were then 
identified by HSQC. The C-Me group  (H3C-17) resonated as at high field (δH 0.97, δC 16.5). HMBC cross-peaks 
from  H3C-20 linked to both H-7 (δ 1.7, δ 1.8), from which C-7 (δ 30.8) was identified by HSQC. A weak 4-bond 
HMBC cross-peak was observed between H-17 and C-6 (δ 74.3), as in 2 and 4. The chemical shift of this carbon 
and of H-6 (δ 3.78) suggested the presence of an oxygen. H-6 had 3-bond HMBC correlations with C-4 (δ 66.9) 
and with C-19 (δ 63.7). HSQC identified the geminally coupled H-19 protons (δ 4.43, δ 4.65). HMBC from 
these latter protons confirmed the lower acetate carbonyl (δ 172.7), linked on to the methyl proton signal at δ 
2.06, co-incident with the other acetate signal. Weak 2-bond HMBC cross-peaks from C-4 identified the oxirane 
protons H-18 at δ 3.01 and δ 3.21, while a stronger 2-bond cross-peak showed H-3 (δ 4.00), with its C-3 (δ 66.5).
The relative stereochemical configurations were largely determined by use of NOESY. An MM2-minimised 
structure suggested that the decalin would have both rings in chair conformations. Strong NOESY cross-peaks 
showed that H-17 and H-20 were cis on the lower face. Similarly,  H2-19 were shown to be on the lower face by 
strong NOESY cross-peaks to H-20, with these methylenes being diaxial on ring B. Further strong cross-peaks 
from both H-19 to H-3 confirmed the latter as axial down on ring A and a cross-peak to H-1 (δ 2.1) also sug-
gested that this was on the lower face. On the upper face, the downfield H-18 signal (δ 3.21) gave a cross-peak to 
H-6 (δ 3.78), which allowed differentiation of the two oxirane proton signals. The relative configuration at C-15 
could not be determined. These data show the structure of 8 (Fig. 1), fatimanol L.
Compound 9. HRESIMS showed pseudomolecular ion peaks at m/z 535.2189 [M +  Na]+ (calc 535.2155) 
and m/z 513.2350 [M +  H]+ (calc 531.2336), corresponding to the formula  C25H36O11. The 13C NMR spectrum 
complied, with 25 discrete signals: 4 ×  CH3, 7 ×  CH2, 7 × CH, 7 ×  Cq. The IR showed OH (3546  cm−1) and three 
carbonyls (1764, 1752, 1708  cm−1). The NMR spectra (Table S3, SI) showed considerable similarity to those for 
8, except in the C-11 / C-12 region and the upper methoxyfuran. The structure of the trans-decalin and the 
lower appendages were identical to those of 8. HMBC from C-11 (δ 38.0) identified H-12 (δ 4.56); the downfield 
chemical shift of this peak indicated a hydroxy group. HSQC identified C-12 (δ 63.8). H-12 was also linked by 
COSY to both H-11 (δ 1.75, δ 1.80). A strong 3-bond HMBC from H-12 showed the signal at δ 144.8 to be due 
to C-14, with HSQC identifying H-14 (δ 7.13). Appropriate HMBC and HSQC correlations then identified C-13 
(δ 144.2), C-15 (δ 104.2), H-15 (δ 5.88) and C-16 (δ 171.7). The methoxy group protons resonated as two singlets 
(δ 3.54, δ 3.55), each integrating for 1.5 H, suggesting that 9 was a mixture of epimers at C-15. The corresponding 
methoxy 13C signal was linked by HMBC to H-15. NOESY also linked together the upper part of the structure. 
Strong cross-peaks were seen linking H-15 with the methoxy group and with H-14. Furthermore, H-14 was 
linked by NOESY with H-12. Addressing the relative configurations of 9 (except for the mixture of epimers at 
C-15), strong NOESY cross-peaks were seen from H-8 (δ 1.94) to H-6 (δ 3.78), to H-10 (δ 2.22) and to H-12, 
showing that all of these are on the upper face of the bicycle. NOESY also linked H-6 with one H-18 (δ 3.17), 
confirming that the latter is on the upper face and differentiating the two H-18 signals. On the lower face, one 
H-19 (δ 4.42) formed a NOESY cross-peak with H-3 (δ 4.00) and the other H-19 (δ 4.71) was close in space with 
H-20 (δ 3.95). The 1H signals for H-2 were differentiated by a NOESY cross-peak from H-10 to H-2ax (δ 2.10). 
The configuration at C-12 could not be determined. The structure is thus 9 (Fig. 1), fatimanol M.
Compound 10. HRESIMS showed a pseudomolecular ion at m/z 425.1452 [M −  H]− (calc 425.1448), cor-
responding to the formula  C20H26O10. Smaller ions were seen at m/z 426.1485 [M −  H]− (calc 426.1481) and 
m/z 427.1520 [M −  H]− (calc 427.1515) for 13C1 and 13C2 isotopomers, respectively. In positive-ion mode, the 
HRESIMS contained the pseudomolecular ion at m/z 427.1596 [M +  H]+ (calc 427.1604), in addition to an abun-
dant ion at m/z 409 [M + H –  H2O]+ showing an aliphatic alcohol. Twenty discrete 13C NMR peaks were evident: 
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1 ×  CH3, 7 ×  CH2, 5 × CH, 7 ×  Cq. Three  Cq were carbonyls, with two coincident 13C NMR signals at δ 174.5 and 
a singleton at δ 173.1, and IR bands at 1795, 1790, and 1689   cm−1. The higher-frequency C = O absorptions 
suggested that they were likely to be a cyclic anhydride. As with other examples, the NMR data (Table S3, SI) 
suggested the neoclerodane skeleton for 10. However, the upper five-membered ring was unusual, in that it was 
a succinic anhydride. Carbonyl C-15 resonated at δ 174.5 and C-16 appeared at δ 173.1. The latter showed a 
3-bond HMBC correlation with one H-14 (δ 2.04). COSY then identified the other H-14 (δ 1.42) and H-13 (δ 
3.1), with HSQC then establishing C-14 (δ 33) and C-13 (δ 49.7). COSY linked H-13 to H-12 (δ 4.76) and HSQC 
identified C-12 (δ 65.8). A 2-bond HMBC from the latter led to assignment of one H-11 (δ 1.89 dd), which was 
shown by HSQC to be attached to the same carbon (C-11, δ 34.2) as the signal at δH 2.43 for the other H-11. An 
additional 2-bond HMBC led to identification of C-9 (δ 36.2). In the lower part, a 3-bond HMBC was observed 
from the methyl H-17 (δ 0.94) to C-7 (δ 41.2). A 3-bond HMBC from H-8 to the hemiacetal carbon (C-6, δ 
108.1) confirmed its location. A further HMBC from C-6 to one H-18 (δ 4.34) showed the closure of the lower 
hemiacetal ring. An MM2-minimised model explained the absence of a HMBC cross-peak from the other H-18 
to C-6, in that the dihedral angle is ca. 90°. H-18 (δ 4.34) also gave an HMBC with C-3 (δ 73.3), which carries 
an oxygen. HSQC then identified H-3 (δ 3.83) as a dd with J = 9.4, 4.6 Hz. The larger coupling constant implies a 
trans-diaxial coupling; thus H-3 is axial. HMBC correlation from H-3 identified C-2 (δ 32.8). A 2-bond HMBC 
linked H-3 with C-4. The (C-19)—O―(C-20) ester bridge was also confirmed by HMBC, in that both H-19 (δ 
4.59 and δ 4.65) showed cross-peaks with C-5 (δ 85.6), C-6 (δ 50.2) and C-20 (δ 174.5). C-19 was identified by 
HSQC at δ 68.5, consistent with the ester. Thus the structure of 10 (fatimanol N) is as in Fig. 1.
Compound 11. Instability under MS conditions precluded obtaining useful mass spectra. The 13C NMR 
showed discrete peaks for 21 carbons: 2 ×  CH3, 6 ×  CH2, 8 × CH, 5 ×  Cq. The IR contained a band for OH 
(3414  cm−1) but no carbonyls. The NMR data (Table S3, SI) showed a neoclerodane structure. The 3-substituted 
aromatic furan was shown by the downfield resonances of the ring-H. H-14 resonated at δ 6.41, while H-15 and 
H-16 were co-incident at δ 7.43. HMBC correlated H-14 with C-13 (δ 126.7), C-15 (δ 143.6) and C-16 (δ 139.3). 
Similarly, H-15 correlated with C-16 and H-16 correlated with C-14 (δ 108.6) and with C-15. HMBC also linked 
C-13, C-13, and C-16 with H-12 (δ 5.10 m) and HSQC identified C-12 at δ 71.6. A COSY cross-peak from H-12 
to the multiplet at δ 1.85 identified the latter as one H-11 and HSQC led to C-11 (δ 40.5) and thence to the other 
H-11 (δ 2.24). C-20 was an acetal carbon, as shown by its chemical shift (δ 101.2), and HSQC identified H-20 as 
the singlet at δ 5.08. H-20 gave HMBC cross-peaks to C-8 (δ 35.2) and C-9 (δ 44.6) and to C-12, demonstrating 
the ether linkage. HMBC from C-8 to both H-11 completed this ring. The C-Me group (C-17, H-17) was readily 
identified as the origin of the most upfield NMR signals (δC 16.3, δH 1.02). From here, a 2-bond HMBC identified 
H-8 (δ 1.85), confirmed by a COSY cross-peak from H-17. Three-bond HMBC interactions also identified both 
H-7 (δ 1.65 t, δ 2.36 dd). These multiplicities indicated that the former was axial and the latter was equatorial. 
C-7 (δ 36.1) was located by HSQC. Acetal C-6 (δ 110.9) was confirmed by 3-bond HMBC with both H-19 (δ 
3.94, δ 4.15, geminally coupled). Both H-19 also gave HMBC cross-peaks to C-20, confirming the ether bridge 
between C-19 (δ 58.5) and C-20. The closure of the lower tetrahydrofuran was demonstrated by HMBC from 
C-6 to both H-18 (δ 3.89, δ 4.42). Moving clockwise around the decalin, HMBC from C-18 (δ 75.1) identified 
H-3 (δ 3.89), the large 3J of which indicated a trans-diaxial relationship with one H-2 (δ 1.41). Further HMBC, 
HSQC, and COSY analysis established the assignments of H-1 (δ 1.95 and δ 1.99), C-1 (δ 23.2), H-2 (δ 1.41 and δ 
2.15), C-2 (δ 30.3) and C-3 (δ 73.2). Thus 11 has the novel polycyclic structure shown in Fig. 1, with many fused 
rings and bridges. Fortunately, these fusions and bridges make the structure fairly rigid and it was straightfor-
ward to assign the relative stereochemical configurations by use of coupling constants (Karplus relationship) and 
NOESY. Figure 2 shows the key NOESY interactions used in this assignment. Particularly useful was the NOE 
interaction between the methoxy protons and H-18exo (δ 3.89), which confirms that the methoxy is on the lower 
face of the trans-decalin. The name fatimanol O is assigned to the novel compound 11 (Fig. 1).
Compound 12. HRESIMS gave pseudomolecular ions at m/z 443.1706 [M +  Na]+ (calc 443.1682) and m/z 
421.1854 [M +  H]+ (calc 421.1862), corresponding to the formula  C22H28O8. The 13C NMR spectrum showed 22 
discrete signals: 2 ×  CH3, 6 ×  CH2, 8 × CH, 6 ×  Cq. The NMR data (Table S4, SI) showed that 12 was a neoclero-
dane. In the upper furan, C-13 resonated at δ 126.7 and gave HMBC cross-peaks to H-14 (δ 6.46), H-15 (δ 7.53) 
and H-16 (δ 7.59). The corresponding 13C resonated at δ 109.2 (C-14), δ 145.6 (C-15) and δ 141.4 (C-16). C-15 
and C-16 were differentiated by HMBC between the latter and H-12 (δ 5.48). HSQC identified C-12 (δ 73.5). 
Three-bond HMBC from C-13 also identified both H-11 (δ 2.38, δ 2.51), from which C-11 was shown to be at δ 
43.6. The downfield H-11 signal also showed HMBC to C-9 (δ 52.0), C-10 (δ 51.8) and carbonyl C-20 (δ 178.9). 
The methyl group gave the most upfield signals (C-17 δ 16.9, H-17 δ 0.99). Strong HMBC cross-peaks identified 
C-8 (δ 38.65) and C-7 (δ 33.5), whereas a weak cross-peak suggested the peak at δ 74.7 as C-6. H-8 resonated 
at δ 1.78 and  H2-7 at δ 1.56, δ 2.22. The chemical shifts of C-6 and of H-6 (δ 4.99) were consistent with an ester 
oxygen and HMBC from H-6 to the carbonyl signal at δ 171.6 confirmed that this appendage was an acetoxy 
group (AcO-) (MeCO2 δC 21.3 δH 2.04). H-6 also gave a strong HMBC to C-5 (δ 48.0) and to C-19 (δ 61.4). The 
diastereotopic H-19 protons gave doublet signals at δ 3.90 and δ 4.62. C-19 gave a strong 3-bond HMBC to H-10 
(δ 1.89). The upfield H-19 gave a 2-bond HMBC with quaternary C-4 (δ 52.8). The relatively upfield chemical 
shift of C-4 was consistent with the oxirane and C-18 (a methylene) was also identified by its chemical shift at δ 
42.5. HSQC then linked it to the doublets for H-18 (δ 2.72, δ 2.80). C-18 gave a moderate HMBC to H-3 (δ 4.28), 
from which COSY and HSQC identified the signals for C-3 (δ 68.7), C-2 (δ 34.1), H-2 (δ 1.45, δ 2.22), C-1 (δ 
23.1) and H-1 (δ 1.78, δ 2.12). Completing ring A, the upfield H-1 gave a strong COSY with H-10. The structure 
of 12 is less rigid than 11 but it was still possible to assign its relative configurations by NOESY (Fig. 2). These 
data confirm the structure of 12, fatimanol P (Fig. 1).
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Compound 13. HRESIMS showed a pseudomolecular ion at m/z 405.1880 [M +  Na]+ (calc 405.1889), cor-
responding to the formula  C20H30O7. Other ions were observed at m/z 787.3875 [2 M +  Na]+ (calc 787.3881). 
Fragment ions were observed at m/z 729.3844 [2  M + Na—C2H2O2]+ (calc 729.3826), m/z 711 [2  M + Na—
C2H2O2—H2O]+, m/z 693 [2 M + Na—C2H2O2—2 ×  H2O]+, m/z 347.1850 [M + Na –  C2H2O2]+ (calc 347.1834), 
m/z 329.1744 [M + Na—C2H2O2—H2O]+ (calc 329.1729), and m/z 311.1639 [M + Na –  C2H2O2—2 ×  H2O]+ (calc 
311.1623), indicating the presence of at least two hydroxy groups. In the negative-ion HRESIMS, peaks were 
seen at m/z 427.1970 [M +  formate]− (calc 427.1968), m/z 417.1689 [M + 35Cl]− (calc 417.1680), and m/z 381.1920 
[M –  H]− (calc 381.1913). The 13C NMR contained signals for 20 carbons: 1 ×  CH3, 7 ×  CH2, 8 × CH, and 4 ×  Cq, 
although two signals were co-incident at δ 143.5.
The NMR data (Table S4, SI) suggested that 13 had a structure broadly similar to those of the neoclerodanes 
but with important differences. The upper ring was a furan, with 1H NMR signals at δ 6.48 (H-14), δ 7.56 (H-15) 
and δ 7.50 (H-16). The signals for H-15 and H-16 were differentiated through COSY from H-15 to H-14 and 
by HMBC from H-16 to C-12 (δ 62.1). HSQC then linked these to the 13C peaks at δ 109.7 (C-14) and δ 143.5 
(C-15, C-16). HMBC from H-14, H-15, and H-16 then identified the signal at δC 132.4 as being due to C-13. 
HMBC from C-13, C-14 and C-16 to the 1H signal at δ 4.68, along with HSQC from C-12, identified this mul-
tiplet signal as H-12. This benzylic proton gave COSY cross-peaks to 12-OH (δ 5.02, d) and both 11-H (δ 1.60, 
δ 2.01, both dd). HSQC from the latter then gave 11-C (δ 41.7). Linkage of this upper side-chain to the core 
bicycle was demonstrated by a HMBC correlation from H-12 to C-9 (δ 40.4,  Cq) and by HMBC from both H-11 
to C-8 (δ 35.6) and to C-10 (δ 51.5). The 3-bond HMBC cross-peak between H-11 (δ 1.60) and C-8 was weak, 
as to the dihedral angle (H-11)–(C-11)–(C-9)–(C-8) is close to 90°. H-8 (δ 1.47) also gave a HMBC with C-11. 
The other side-chain at C-9 was a hydroxymethyl  (HOCH2-) unit, with C-20 (δ 53.3) giving weak HMBC with 
both H-11. The geminal protons H-20 (δ 3.21, δ 3.32) gave strong COSY interactions with each other and with 
HO-20 (δ 4.46). The methyl group was at C-8, as shown by COSY from H-8 to the doublet at δ 0.71 (H-17), 
from which HSQC identified C-17 (δ 16.3). Moving clockwise around the B-ring, a strong 2-bond HMBC from 
C-8 identified  Hax-7 at δ 1.21 (q, J = 11 Hz). HSQC revealed C-7 (δ 37.9) and thence  Heq-7 (δ 1.47). Both H-7 
gave strong 2-bond HMBC correlations with C-6 (δ 69.4), from which HSQC showed H-6 at δ 3.36. The COSY 
cross-peak from  Hax-7 to H-6 was strong, whereas that from  Heq-7 to H-6 was much weaker, suggesting that the 
 (Heq-7)–(C-7)–(C-6)–(H-6) dihedral angle was ca. 90° and thus that H-6 was axial. COSY linked H-6 to HO-6 (δ 
4.46). Three-bond HMBC from both H-7 located quaternary C-5 (δ 59.8). Ring B was completed by observation 
of a 2-bond HMBC from C-5 to H-10 (δ 2.07).
Figure 2.  Upper: Key NOESY interactions confirming the relative stereochemical configurations of the rigid 
polycycle 11. Lower: Key NOESY interactions confirming the relative stereochemical configurations of 12. A 
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A 2-bond HMBC from H-10 identified C-1 (δ 24.6), from which HSQC showed that the H-1 signals were at 
δ 1.87 and δ 1.98. A strong 3-bond HMBC linked C-10 with one H-2 signal (δ 1.87), whereas the cross-peak to 
the other H-2 (δ 1.27) was weaker. A 3-bond HMBC was also seen linking H-1 (δ 1.27) to C-5; the 3-bond path 
between these two nuclei cannot pass through C-1 and C-10, thus ring A must be five-membered. Quaternary 
C-3 (δ 57.7) was identified through a 2-bond HMBC with H-2 (δ 1.27) and a 3-bond correlation with H-10, 
completing the cyclopentane. Three-bond HMBC from both H-2 showed the methylene C-4 (δ 62.5) as being 
attached at C-3 and the H-4 protons were observed as dd at δ 3.27 and δ 3.66. These H-4 signals were linked 
by COSY to each other and to HO-4 (δ 4.46). A 2-bond HMBC between H-4 (δ 3.27) and C-3 confirmed the 
attachment of the  HOCH2-. 2-bond HMBC from C-3 and a 3-bond cross-peak from H-2 (δ 1.27) revealed the 
other substituent at C-3 by identifying C-18 (δ 102.0). The hemiacetal was confirmed by COSY from H-18 (δ 
4.76) to HO-18 (δ 6.26). HMBC from C-5, C-6 and C-10 to the doublet signals at δ 3.80 and δ 3.87 identified 
both H-19. C-19 (δ 67.3) was shown to be a  CH2 by HSQC and 135DEPT. The chemical shifts of C-19 and both 
H-19 suggested the attachment of an oxygen but this was not an OH (no COSY cross-peak). However, HMBC 
linked C-19 with H-18 and C-18 with both H-19. The only structure consistent with these connectivities is the 
cyclic acetal shown. It was not possible to obtain a good NOESY spectrum, so the relative configuration shown 
in Fig. 1 is speculative, except where suggested by 3JH-H coupling constants. The NMR spectra contained a second 
(smaller) set of peaks, which we ascribe to the presence of a minor diastereoisomer in slow equilibrium, probably 
the epimer at C-18. Thus 13 (fatimanol Q) has the structure in Fig. 1.
Compound 14. HRESIMS showed a pseudomolecular ion m/z 447.1985 [M +  Na]+ (calc 447.1995), consist-
ent with the formula  C22H32O8. Other ions were at m/z 871.4083 [2 M +  Na]+ (calc 871.4091) and m/z 425.2167 
[M +  H]+ (calc 425.2175) in positive-ion mode and 469.2075 [M +  formate]− (calc 469.2074), and 459.1795 
[M + 35Cl]− (calc 459.1786) in negative-ion mode. The 13C NMR spectrum (in  (CD3)2SO) contained discrete 
signals for 22 carbon atoms: 2 ×  CH3, 7 ×  CH2, 8 × CH, 5 ×  Cq.
Analysis of the NMR data ((CD3)2SO, Table S4, SI) showed that 14 was a conventional neoclerodane. The 
upper ring was a furan, with 1H signals for H-14 (δ 6.42), H-15 (δ 7.56) and H-16 (δ 7.49) and 13C signals for 
C-13 (δ 132.8), C-14 (δ 109.6), C-15 (δ 143.6) and C-16 (δ 138.6) all duly linked by HSQC and HMBC. Strong 
3-bond HMBC cross-peaks were evident from H-12 (δ 4.59) to C-14 and C-16. HSQC linked this proton to C-12 
(δ 61.7), which also gave HMBC to H-14 and H-16. A 2-bond HMBC from H-12 identified C-11 (δ 39.7), from 
which both H-11 (δ 1.67, δ 1.86) were identified by HSQC. HO-12 (δ 4.90) was located through a 3-bond HMBC 
from C-11. A 3-bond HMBC from H-12 identified C-9 (δ 43.3), while a similar correlation from H-11 (δ 1.67) 
confirmed C-10 (δ 46.8) and thence H-10 (δ 1.96). From here, C-20 (δ 63.0) was located by HMBC to H-10; the 
H-20 protons were approximately co-incident at δ 3.28, with HMBC cross-peaks to C-9 (weak, 2-bond), C-10, 
and C-11. Two-bond HMBC linked C-10 to both H-1 (δ 1.75, δ 2.00), from which C-1 (δ 21.5) was identified 
by HSQC. The upfield H-1 signal gave a weak 2-bond HMBC with C-2 (δ 34.5), whereas the downfield signal 
correlated strongly with C-3 (δ 65.0). The signal at δ 1.17 was a dq (J = 4, 11 Hz), indicating that this was due to 
H-2ax, while H-2 eq resonated as a narrow multiplet at δ 1.91. Thus the coupling to H-3 (δ 3.80) shows that this 
proton is axial and HO-3 is equatorial . Furthermore, both H-3 and H-10 are axial, showing that ring A is in the 
chair conformation. A 2-bond HMBC from H-3 identified C-4 (δ 70.0) and a 3-bond correlation revealed C-18 
(δ 43.0).  H2-18 resonated as doublets at δ 2.83 and δ 3.06; the chemical shifts suggested the spiro-oxirane ring. 
Strong HMBC from these protons were observed to C-4 and C-5 (δ 45.47). An  AcOCH2- group was present at 
C-5, as demonstrated by HMBC from both H-19 (δ 4.40, δ 4.57) to C-4 and C-5. These protons also correlated 
with the ester carbonyl MeCO2-19 (δ 170.8), with the adjacent methyl group (MeCO2-19) resonating at δH 2.01/
δC 21.5. Three-bond HMBC cross-peaks were also seen from both H-19 to C-6 (δ 73.3) and HSQC then located 
the H-6 signal at δ 3.62 (brd, J = ca. 11 Hz). The H-6 signal was better resolved when the 1H NMR spectrum was 
obtained on a solution in  CDCl3, which showed it as δ 3.70 (dd, J = 10.0, 6.0 Hz). The larger axial-axial coupling 
shows that H-6 is axial on the trans-decalin. Both H-7 (δ 1.39, δ 1.52) were located both by HSQC with C-7 and 
by HMBC with C-6, whence C-7 (δ 34.7) was revealed by HSQC. H-7 also formed HMBC correlations with 
the methyl C-17 (δ 17.0), from which H-17 was identified at δ 0.82. Completing ring B, H-17 gave an HMBC 
cross-peak with C-9. These spectroscopic interpretations were aided, in part, by 1H, COSY and HSQC spectra 
of a solution in  CDCl3, which were better resolved, although paucity of sample precluded identification of the 
quaternary carbons (Table S4). The coupling constants confirmed of the trans-decalin structure and the relative 
configurations of most of the substituents, although the relative configuration at C-12 could not be established. 
We assign the structure shown in Fig. 1 to 14, fatimanol R.
Compound 15. The HRESIMS contained a pseudomolecular ion at m/z 379.1748 [M +  H]+ (calc 379.1757), 
which showed the formula  C20H26O7. Other ions were observed at m/z 779.3248 [2 M +  Na]+ (calc 779.3255), m/z 
401.1567 [M +  Na]+ (calc 401.1576), m/z 361.1642 [M + H—H2O]+ (calc 361.1651), 343.1537 [M + H—2 ×  H2O]+ 
(calc 343.1546), and m/z 325.1341 [M + H—3 ×  H2O]+ (calc 325.1440). The latter three ions indicated the pres-
ence of three hydroxy groups. Negative ions were present at m/z 423.1656 [M +  formate]− (calc 423.1655), and 
m/z 377.1605 [M −  H]− (calc 377.1600). The 13C NMR spectrum (in  (CD3)2SO) contained individual signals for 
20 carbon atoms: 1 ×  CH3, 6 ×  CH2, 8 × CH, 5 ×  Cq. The NMR data (Table S5, SI) for 15 indicated a conventional 
neoclerodane. The upper furan showed 1H signals for H-14 (δ 6.49), H-15 (δ 7.74) and H-16 (δ 7.78). HSQC 
linked these to C-14 (δ 109.1), C-15 (δ 145.0) and C-16 (δ 141.1), respectively. The C-13 13C NMR signal was 
identified at δ 125.6 by HMBC. Moving south, 3-bond HMBC cross-peaks from C-14 and C-16 identified H-12 
as a triplet at δ 5.43. The HMBC from C-16 to H-12 and the NOESY interaction between H-16 and H-12 dis-
tinguished H-16 from H15. The chemical shift of H-12 suggested that it carried a lactone oxygen, confirmed by 
HMBC from H-12 to C-20 at δ 177.0. HSQC linked H-12 to C-12 (δ 71.4). A 2-bond HMBC linked H-12 to 
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C-11 (δ 41.2), with HSQC from this signal  H2-11 (δ 2.25, δ 2.45). Both H-11 gave HMBC correlations to the 
lactone carbonyl C-20, further confirming the ring. Both H-11 also gave HMBC cross-peaks to the quaternary 
carbon (δ 51.2), which was shown to be C-9 where the spiro-lactone joins the decalin. Working clockwise around 
the lower decalin, C-19 gave a strong HMBC to the methyl H-17 protons (δ 0.91), from which C-17 (δ 16.9) was 
identified. A 2-bond HMBC from H-17 located C-8 (δ 37.3) and a 3-bond correlation located the methylene C-7 
(δ 34.9), HSQC then showed H-8 (δ 1.62) and both H-7 (δ 1.48 (H-7 eq), δ 1.96 (H-7ax)). C-7 showed a 2-bond 
HMBC with H-6 (δ 3.67); this chemical shift indicates an attached alcohol. C-6 (δ 72.5) was shown by HMBC 
with H-7 eq and HSQC with H-6. The signal for 6-OH was broad but gave HMBC correlation with C-6. The 
signal at δ 46.4 was due to C-5. HMBC interactions then tied C-5 to the attached  CH2OH group (H-19 δ 3.69, 
δ 4.36; HO-19 δ 4.07) and HSQC identified C-19 (δ 59.3). Both H-19 gave strong 3-bond HMBC cross-peaks 
to quaternary C-4 (δ 68.8), which was shown to be part of a spiro-oxirane. In the oxirane, H-18left resonated 
as a doublet at δ 2.69 and H-18right as a doublet at δ 2.89. These diastereotopic protons were distinguished by 
NOESY correlations from H-18left to HO-3 (δ 4.66) and one H-2 (δ 1.30) and from H-18right to H-19 (δ 3.69), 
H-6 and HO-6. Three-bond HMBC from both H-18 identified C-3 (δ 64.3), from which H-3 (δ 4.19) was shown 
by HSQC. HMBC from C-3 identified its HO-3 as a doublet at δ 4.66. The ring was completed by appropriate 
HMBC and HSQC cross-peaks identifying C-2 (δ 34.1), H-2 (δ 1.30, δ 2.05), C-1 (δ 22.0) and H-1 (δ 1.59, δ 
1.96). Finally, there was a strong HMBC linking H-2 (δ 1.30) with C-10 (δ 51.2), closing the ring. H-10 resonated 
at δ 1.67.
The relative configurations were largely demonstrated by NOESY, with some consideration of 1H J values. 
Firstly, a strong NOESY interaction was seen between H-16 and H-17 and a weaker one between H-14 and H-17. 
This demonstrates that the furan and the methyl group are on the same face of the lactone and that the configura-
tion at C-12 is S. The signal for H-7 (δ 1.48) is a broad doublet, thus this proton is equatorial up as the only large 
coupling constant would be 2Jgem to H-7ax (δ 1.96). The methyl (C-17, H-17) is equatorial down, as for the vast 
majority of neoclerodanes. H-7ax makes a strong NOESY interaction with H-19 (δ 4.36), consistent with C-19 
being axial down. HO-6 is located on the lower face of the decalin, as H-6 experiences a strong NOESY correla-
tion with H-7 eq on the upper face. Running the spectrum in DMSO also allowed a NOESY interaction between 
HO-6 and H-19 (δ 4.36), confirming the orientation of HO-6. The configuration at C-4 of the spiro-oxirane was 
determined. H-1 (δ 1.59) is axial and down, as it has three large coupling constants (trans-diaxial to H-10 and 
H-2 (δ 1.30) and geminal to H-1 eq (δ 1.96)). Therefore, H-2 (δ 1.30) is axial up. H-18left (δ 2.69) makes strong 
NOESY contacts with H-2ax and with HO-4 (upper face), which shows that the  CH2 of the oxirane is on the upper 
face, as in 2, 8, 9, and 12. Finally, H-10 is on the upper face, as it shows a trans-diaxial coupling to H-1ax. Thus the 
bicycle is a trans-decalin. These spectroscopic assignments were aided partly by 1H, COSY, and HSQC spectra 
obtained of a solution in  CDCl3, which were better resolved, although shortage of sample precluded identifica-
tion of the quaternary carbons (Table S5). Minor differences in chemical shift were seen for H-2 eq, H-3, H-14, 
H-15, H-18, and H-19, probably reflecting minor changes in hydrogen-bonding and consequent minor changes 
in conformation. The COSY spectrum confirmed the H–H connectivities within the molecule. We assign the 
structure shown in Fig. 1 to 15, fatimanol S.
Compound 16. The HRESIMS contained a pseudomolecular ion at m/z 379.1748 [M +  H]+ (calc 379.1757), 
consistent with the formula  C20H26O7. Ions were also seen at m/z 779.3250 [2 M +  Na]+ (calc 779.3255), m/z 
401.1568 [M +  Na]+ (calc 401.1576), 361.1643 [M + H −  H2O]+ (calc 361.1651), and m/z 325.1432 [M + H − 
3 ×  H2O]+ (calc 325.1440), indicating three OH groups. The 13C NMR spectrum (in  (CD3)2SO) contained signals 
for 20 carbon atoms: 1 ×  CH3, 6 ×  CH2, 8 × CH, and 5 ×  Cq. Therefore, 16 is a closely structurally related isomer 
of 15. Analysis of the COSY, HSQC, HMBC and some NOESY connectivities showed an identical network to 
15, strongly suggesting that they were stereoisomers. The NMR signals (in  (CD3)2SO, Table S5, SI) for the lower 
part of the structure were very similar: position-2 (δH 1.20, δH 2.00, δC 34.1), position-3 (δH 4.16, δC 64.5), posi-
tion-4 (δC 68.8), position-5 (δC 46.2) and position-6 (δH 3.65, δC 72.5). Slightly more significant differences in 
chemical shift were observed for the upper and right parts of the decalin, at position-1 (δH 1.43, δH 1.68, δC 
21.5), position-7 (δH 1.42, δH 1.74, δC 35.6), position-8 (δH 1.74, δC 40.0), and position-10 (δH 1.50, δC 49.2). The 
signal for C-9 (δ 51.5) was identical in 16 and 15. In the upper spiro-lactone, the differences were again observed 
for position-11 (δH 2.33, δH 2.41, δC 42.6) but less significant for position-12 (δH 5.42, δC 71.3) and the lactone 
carbonyl C-20 (δ 176.8). Small differences were also seen for the furan: position-13 (δC 125.8), position-14 (δH 
6.51, δC 109.3), position-15 (δH 7.71, δC 145.0) and position-16 (δH 7.77, δC 140.7). The larger differences were in 
the upper part of the decalin and in the lactone, which suggested that the stereochemical difference between 16 
and 15 was at C-9 or at C-12. A detailed study of NOESY data in that area was undertaken. Firstly, the equato-
rial methyl H-17 gave a strong NOESY cross-peak to H-12, thus these were on the same face of the γ-lactone. 
Secondly, H-12 gave a strong NOESY correlation with one H-11 (δ 2.41) but only weakly with the other H-11 
(δ 2.33). Since the furan protons H-14 and H-16 both formed strong NOESY cross-peaks with H-11 (δ 2.33), 
the furan and this upfield H-11 must be on the same face of the γ-lactone and this face must be opposite to that 
carrying H-12. These data are consistent with 16 having the opposite configuration at C-12 from 15. Other 
NOESY interactions, COSY cross-peaks and 1H-1H coupling constants in the decalin were consistent with trans-
configuration. The spectroscopic assignments were aided, in part, by 1H, COSY, and HSQC spectra of a solution 
in  CDCl3, which were better resolved, although shortage of sample precluded identification of the quaternary 
carbons and NOESY data could not be obtained. We assign the structure shown in Fig. 1 to 16, fatimanol T.
Compound 17. The HRESIMS contained a pseudomolecular ion at m/z 503.1886 [M +  Na]+ (calc 503.1893), 
confirming the formula  C24H32O10. Other positive ions at m/z 983.3881 [2 M +  Na]+ (calc 983.3889), m/z 481 
[M +  H]+, m/z 463.1961 [M + H −  H2O]+ (calc 463.1968), m/z 445.1856 [M + H − 2 ×  H2O]+ (calc 445.1862), 
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m/z 421 [M + H −  AcOH]+, m/z 403.1750 [M + H −  H2O −  AcOH]+ (calc 403.1757), and m/z 361.1644 [M + H 
− 2 ×  AcOH]+ (calc 361.1651) confirmed the formula and indicated at least two hydroxy groups and at least two 
acetate esters. Negative-mode ions were present at m/z 525.1974 [M +  formate]− (calc 525.1972), m/z 515.1693 
[M + 35Cl]− (calc 515.1684), and m/z 479.1923 [M −  H]− (calc 479.1917). The 13C NMR spectrum (in  (CD3)2SO) 
contained discrete signals for 24 carbon atoms: 3 ×  CH3, 6 ×  CH2, 8 × CH, 7 ×  Cq. Compound 17 was a conven-
tional neoclerodane. As for 15, the upper part of the structure was a furan linked to a γ-lactone. H-14, H-15, 
and H-16 resonated at δ 6.51, δ 7.71 and δ 7.79, respectively, with the carbon signals at δ 109.1 (C-14), δ 144.9 
(C-15) and δ 141.2 (C-16) (Table S6, SI). C-13 (δ 125.7) was identified through HMBC interactions with H-15 
and H-16. HMBC from H-16 also revealed C-12 (δ 74.1), from which H-12 (δ 5.45) was shown by HSQC. COSY 
then linked H-12 to both H-11 (δ 2.32 and δ 2.45) and thence by HSQC to C-11 (δ 43.1). The chemical shift 
of H-12 confirmed the lactone and 3-bond HMBC from both H-12 identified the lactone carbonyl C-20 at δ 
177.1. The lactone was tied to the decalin through HMBC from the upfield H-11 to C-8 (δ 37.7). H-8 resonated 
at δ 1.70 and this signal correlated in HMBC with the methyl group (H-17 δ 0.96, C-17 δ 16.8). Strong HMBC 
cross-peaks linked C-17 to both H-7 (δ 1.54, δ 1.87) and thence by HSQC to C-7 (δ 36.1). HMBC from H-8 and 
both H-7 to the signal at δ 72.8 identified the latter as C-6. H-6 (δ 4.20) gave HMBC correlations to C-5 (δ 48.2) 
and C-4 (δ 76.9). The downfield chemical shift of C-4 indicated an oxygen but contraindicated a spiro-oxirane. 
 H2-19 of the pendant methylene resonated as a pair of geminally coupled doublets at δ 4.77 and δ 4.86, which 
were linked by HMBC to C-5 and C-4. The chemical shifts of  H2-19 suggested an AcO- group and this was 
confirmed by HMBC to 19-MeCO2, which linked onwards to the acetate methyl (δH 2.00, δC 169.9). H-18 / C-18 
is a pendant  HOCH2- group, with 2-bond HMBC from both H-18 (δ 3.73 and δ 4.04) to C-4 and 3-bond cross-
peaks to C-5. Both  H2-18 resonated as dd, with 2J = 10 Hz and smaller couplings to HO-18 (δ 5.06). This spin-set 
was confirmed by COSY. A 3-bond HMBC identified C-3 (δ 71.4). H-3 (δ 5.45) had a HMBC cross-peak with a 
carbonyl at δ 170.4, demonstrating that the oxygen at C-3 was acetylated. The methylenes at position-2 and posi-
tion-1 were also identified by application of HMBC, (C-2 δ 36, H-2 δ 1.80, δ 2.45; C-1 δ 22.6, H-1 δ 1.95, δ 2.0). 
The closure of the decalin system was confirmed by a weak HMBC from C-2 to H-10 (δ 1.80) and a strong peak 
from C-4 to H-10. The above spectroscopic assignments were aided by 1H, COSY, HSQC, and HMBC spectra 
of a solution in  CDCl3, which were better resolved, although shortage of sample precluded identification some 
quaternary carbons. The relative configurations corresponded to those of most of the neoclerodanes, particularly 
15, as demonstrated largely by 1H NMR coupling constants. The structure shown in Fig. 1 was assigned to 17, 
fatimanol U.
Compound 18. The HRESIMS contained ions at m/z 803.3255 [2 M +  Na]+ (calc 803.3255) and m/z 413.1568 
[M +  Na]+ (calc 413.1576) confirming the formula  C21H26O7. An ion was also seen at m/z 371 [M +  H]+. The 13C 
NMR spectrum (in  (CD3)2SO) contained discrete signals for twenty-one carbon atoms: 3 ×  CH3, 4 ×  CH2, 8 × CH, 
6 ×  Cq. Combined analysis of the NMR data (Table S6, SI) allowed assignment of all the signals and confirmed 
that the overall structure was similar to a conventional neoclerodane. However, C-6 was quaternary but not a 
carbonyl (cf. 2). Two methoxy groups were also evident. The upper part of the structure was a furan, with the 
usual chemical shifts (position-13: δC 125.4; position-14: δH 6.52, δC 109.2; position-15: δH 7.72, δC 145.0; posi-
tion-16: δH 7.82, δC 141.2). HMBC cross-peaks from C-13 linked this to H-12 (δ 5.48) and to one H-11 (δ 2.42). 
The other H-11 (δ 2.57) was identified by COSY cross-peaks to H-12 and to its geminal partner H-11. HSQC 
then located C-12 (δ 71.6) and C-11 (δ 40). The carbonyl (C-20) of the γ-lactone resonated at δ 176.6 and showed 
an HMBC cross-peak to the downfield H-11. It also gave an HMBC with H-10 (δ 2.45) and both H-11 gave 
HMBC correlations with C-9 (δ 53.0), confirming the attachment of the spiro-lactone. In the lower bicycle, H-10 
also correlated in HMBC with C-8 (δ 35.8), from which H-8 (δ 2.01) and the methyl doublet H-17 (δ 0.92) were 
identified. COSY from H-8 led to one H-7 (δ 1.87) and thence to its geminal partner H-7 (δ 2.27). HSQC identi-
fied C-7 (δ 39.6). Two-bond HMBC linked both H-7 to C-6 (δ 109.16). This chemical shift implied that C-6 was 
an acetal or hemiacetal carbon, confirmed by a 3-bond HMBC with the upfield methoxy group MeO-6 (δ 2.97). 
Both H-7 also showed HMBC correlations to C-5 (δ 137.4), an alkene carbon. Thus C-19 is missing from the 
usual neoclerodane structure. H-10 is present, thus the other alkene carbon is C-4 (δ 139.5). HMBC from C-4 
located HO-3 (δ 5.06), from which H-3 was shown (COSY) to be at δ 4.06 and thence C-3 was identified at δ 51.5 
by HSQC. COSY joined H-3 to both H-2 (δ 1.39, δ 2.01) and HMBC from HO-4 identified C-2 (δ 33.0).  CH2-1 
resonated at δH 1.25, δH 2.27, and δC 23.7. In the bottom dihydrofuran, HMBC from C-3 and C-5 identified H-18 
(δ 6.02) and HSQC confirmed C-18 (δ 107.0), where the chemical shifts were consistent with an acetal. One arm 
of this acetal was the oxygen linking through to C-6 and the other was a methoxy (MeO-18) (δH 3.15, δC 51.5), 
as shown by HMBC to H-18 and C-18. Turning to the configuration of 18, the 1H chemical shift of MeO-6 was 
unusually low (δ 2.97). Examination of a molecular model showed that this methyl group, if on the lower face, 
would be held in the anisotropic shielding zone of the C-20 carbonyl; thus it is likely to be located on the lower 
face. The configuration at the other acetal C-18 could not be determined, although it was clear that only one 
diastereoisomer was present. A 1H NMR spectrum of 18 was also obtained in  CDCl3, which was consistent with 
the structure determined above. The novel structure shown in Fig. 1 was assigned to 18, fatimanol V.
Compound 19. Instability under MS conditions precluded obtaining useful spectra. The 13C NMR spec-
trum (in  (CD3)2SO) (Table S7, SI) contained twenty-two discrete 13C signals: 3 ×  CH3, 8 ×  CH2, 5 × CH, 6 ×  Cq. 
The combined spectra showed it to be a modified neoclerodane. The upper ring was a furanone, with the H-16 
protons resonating accidentally equivalently as a singlet at δ 4.86, with C-16 at δ 73.53. These chemical shifts 
suggested a γ-lactone. Three-bond HMBC cross-peaks from H-16 identified lactone carbonyl C-15 (δ 173.4) and 
C-14 (δ 114.0), with H-15 (δ 5.96) identified by HSQC. A 2-bond HMBC identified C-13 (δ 174.4). Initially, it 
was unexpected that the resonance for C-13 (an alkene) would be downfield of that for C-15 (a carbonyl) but 
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comparison with the chemical  shifts29 for 4-ethyl-5H-furan-2-one gave precedent. Moreover, the assignment 
was shown to be correct by HMBC from H-12 (δ 2.25) to C-13. HSQC then identified the other H-12 (δ 2.15) 
and C-12 (δ 21.9). HMBC from both H-12 led to C-11 (δ 34.38), confirmed by interactions of C-12 with both 
H-11 (δ 1.50, δ 1.98). C-9 resonated at δ 38.0 and was linked by HMBC to the two upfield methyl signals, δ 0.78 
for H-17 and δ 0.65 for H-20. A 3-bond HMBC from H-20 led to C-10 (δ 46.3) and thence H-10 (δ 1.38). C-10 
formed a HMBC cross-peak to H-8 (δ 1.24), from which C-8 (δ 4.1) was identified by HSQC. Confirmation was 
supplied by HMBC from C-8 to C-17 and C-20. A weak 4-bond HMBC from H-17 to C-6 (δ 72.7) identified 
the latter. H-6 resonated at δ 3.63. HMBC from C-6 to δH 1.43 led to identification of one H-7, from which the 
other H-7 (δ 1.50) and C-7 (δ 34.41) were correlated by HSQC. C-6 also gave an HMBC with H-10, closing the 
lower-right carbocycle, while a cross-peak from the upfield H-7 located C-5 (δ 45.2). C-5 was shown to carry 
C-19 by HMBC to both H-19 (δ 4.34, δ 4.49, geminally coupled doublets). Both H-19 linked on to the carbonyl 
at δ 170.8, demonstrating that C-19 carries an AcO- group. C-5 also gave HMBC cross-peaks to both H-18 (δ 
2.84, δ 3.09). HSQC identified C-18 (δ 43.0) and 2-bond HMBC from both H-18 located the signal for C-4 at δ 
69.6. A weaker HMBC interaction between C-4 and HO-3 (δ 7.76) linked on to C-3 (δ 64.5) and thence H-3 (δ 
3.82). Finally, the remaining  CH2s were identified through further HMBC (H-2: δ 1.24, δ 1.55, C-2 δ 34.42; H-1: 
δ 1.50, δ 1.66, C-1 δ 20.0). The structure shown in Fig. 1 was assigned to 19, fatimanol W.
Compound 20. Instability under MS conditions precluded obtaining useful spectra. The 13C NMR spectrum 
(in  (CD3)2SO) (Table S7, SI) contained twenty discrete 13C signals: 2 ×  CH3, 8 ×  CH2, 5 × CH, and 5 ×  Cq. The 
combined NMR spectra showed it to be very similar to 19, with similar HMBC and HSQC connectivities. This 
compound lacked an acetate ester. Relative to 19, the signals for H-19 and C-19 have moved markedly upfield 
(δH 3.78, δH 3.98, δC 60.3). This was consistent with the C-19 substituent being HO-. This was confirmed by 
observation of the HO-19 signal as a dd at δ 4.12, with HMBC to C-5 and C-19. Changes in chemical shift were 
also seen for the oxirane H-18 (δ 2.70, δ 2.89) and C-18 (δ 40.5), and for C-5 (δ 46.9), reflecting changes in steric 
effects in that region and the absence of through-space effects from an ester carbonyl. Thus 20 (fatimanol X) was 
the desacetyl analogue of 19, as shown in Fig. 1.
The occurrence of orthoesters in plant natural products was reviewed by Liao et al. in  200828. Orthoacetates 
have been reported in only a limited number of frameworks, principally the daphnane diterpenoids, phrag-
malin limonoids, bufadienolide and ergostanoid steroids. Several of these orthoacetates have potent biological 
activities, including systemic toxicity. In each case, the three oxygen atoms of the orthoacetate unit were situated 
appositely in space for formation of the orthoester and the rigidity of the framework of the diterpene contributed 
to the stability of this usually highly acid-labile functionality. We propose the mechanism shown in Fig. 3 for 
formation of the orthoacetate in 1. Proposed intermediate 23 is 19-acetylteulepicin, reported by Savona et al.16 
to be a secondary metabolite in T. buxifolium and the formal oxidation product of 2 at the lactol. It is therefore 
feasible that 23 is the true biosynthetic precursor of 1 in T. yemense. The carbonyl oxygen of the acetate attacks 
Figure 3.  Proposed mechanism of tandem cyclisations forming orthoester 1 from acetate ester 23, noting 
apposite positions of ketone and oxirane electrophiles.
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the adjacent electrophilic ketone carbonyl from the lower face, generating intermediate 24. Here the alkoxide 
anion is held close to the  CH2 of the electrophilic oxirane and attacks it, opening the strained ring and forming a 
new bond. Finally, the new alkoxide in 30 is perfectly placed for attack as the electrophilic carbon of the acetate 
to form the orthoester 1. Bruno et al.30 observed a related cyclisation from pyrolysis of fruticolone (a constituent 
of T. fruticans) at 200 °C and a chemical acid-catalysed epoxyester-orthoester rearrangement has been  reported31 
in a synthesis of petuniasterone D.
Neoclerodanes with the A-ring contracted to a cyclopentane, as in 13, have been reported previously as plant 
natural products but with more complex substitution patterns. Examples with a cyclobutene fused to the cyclo-
pentane were reported in the 1980s.32,33 Ring-contracted neoclerodanes were later  identified34–37 from Pteronia, 
Conyza, and Microglossa species. In these neoclerodanes, there is extensive transannular bridging. Fatimanol Q 
13 is the simplest ring-contracted neoclerodane identified to date. Bohlmann’s group suggested that their ring-
contracted compounds arose from rearrangements involving migration of C-2 to bond with C-4. Mechanisms 
proposed include protonation of a hydroxy group at C-4 to initiate the rearrangement,34 trapping the aldehyde 
formed from C-3 with a hydroxy group at C-1034,35 and formation of a C-1 = C-10 double bond.34,36,37 In each case, 
the C-10 position is oxidised. However, in the present case, C-10 is not oxidised with either an oxygen function 
or an alkene. We propose the mechanism in Fig. 4 for the biosynthetic ring-contraction. In this mechanism, the 
rearrangement is triggered by protonation and ring-opening of the strained oxirane. The leaving group oxygen 
is on the lower face of the ring and thus almost antiperiplanar to the C-3–C-2 bond. The oxirane-opening and 
the migration of C-2 are probably concerted, given this conformation. C-2 will approach C-4 from the opposite 
side to the leaving group, resulting in stereochemical inversion at C-4. This places C-18 on the upper face and 
the newly generated carbocation (C-3) on the lower face, where it can readily form a hemiacetal with HO-19. 
This hemiacetal closes the second 5-membered ring such that the two 5-membered rings are cis-fused, an ener-
getically favoured arrangement.
Acid anhydrides are relatively uncommon in natural products, owing to their potential for electrophilic reac-
tivity and hydrolysis. However, we have firmly identified 10 as having a succinic anhydride as the upper ring; this 
is the first such neoclerodane to be reported. Only one natural product containing a simple (non-fused) succinic 
anhydride, tubogenic anhydride A, has previously been isolated, from Aspergillus tubingensis38.
Compounds 2,3,7–9,11,12,14–17,19,20 contain the conventional neoclerodane carbon framework with 
various differences in oxidation level, acetylation, bridging rings and ring-opening at the C-4/C-18 oxirane, 
whereas 4–6,18 lack C-19. The C-12–C-20 lactol in 2 has precedent in gnaphalin (isolated from T. gnaphalodes)39, 
although the latter lacks HO-3. The C-19–C-20 bridging lactone of 3,7,10 is present in  teulepicephin15 and many 
other neoclerodanes. Compound 11 contains a related bridging acetal, giving a rigid polycyclic structure. This 
polycycle is also present in teucrin  P1 (also from T. gnaphalodes)40, teupyrenone (from T. pyrenaicum)41, and 
teupolin  III42, although the latter do not have the additional lower fused tetrahydrofuran to stiffen the structure 
further. The upper hydroxyfuranone hemiacetal in 7 is also present in the neoclerodane salvidivin (from Salvia 
divinorum)22, whereas the methoxyfuranone acetal moiety in 8,9 has precedent in the labdane 15-methoxyvelu-
tine C (from Marrubium thessalum)43. Most neoclerodanes have the 12-S configuration, so the identification of 16 
as a 12-R neoclerodane is noteworthy. Gács-Baitz et al.42 used NOE NMR spectroscopy to determine configura-
tion at C-12 in neoclerodanes featuring the upper aromatic furan and the spiro-lactone but did not have an exact 
epimeric pair for their study; 15 and 16 are exact epimers which facilitated their stereochemical identification. 
The lower hydroxyfuranone hemiacetal of 4,5 and the corresponding methoxyfuranone acetal feature of 6 have 
scant precedent, in teucvisin  C44 and cracroson  B45, respectively, while the dimethoxydihydrofuran diacetal of 
18 is completely novel in the series. The ajugamarins and related neoclerodanes have the upper furanone unit of 
19 and 20 but all known ajugamarins are oxygenated at C-1246.
Compounds 1–12 were evaluated for their ability to enhance the glucose-triggered secretion of insulin by 
freshly isolated murine pancreatic islets, using our previous  assay47. In negative-control islets, insulin secre-
tion was 9.1 ± 0.3 ng  islet−1  h−1, triggered by glucose (16.7 mM) (Fig. 5). This release was increased 2.2-fold by 
Figure 4.  Proposed mechanism of rearrangement/ring-contraction of 26 to form 13.
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the standard drug tolbutamide (20.2 ± 1.3 ng  islet−1  h−1). The tested compounds showed a range of activities. 
Compounds 1,2,12 showed little or no effect on the secretion of insulin. Compounds 3–6 and 11 increased 
the glucose-triggered release of insulin by approximately the same extent as the positive control tolbutamide. 
Encouragingly, 7–10 showed strong enhancement of insulin secretion, by 3–4 × , although not as potently as the 
coumarins cluteolin D and clueolin J (from Clutia lanceolata)48.
Conclusions
We report the isolation and identification of twenty new neoclerodanes from the traditional medicinal plant T. 
yemense. Compound 1 contains an orthoacetate, which is previously unreported in naturally-occurring neo-
clerodanes. As shown (Fig. 3), the acetate, oxirane and ketone groups in proposed precursor 23 are appositely 
located to facilitate formation of the orthoester; precursor 23 is 19-acetylteulepicin, previously identified in T. 
buxifolium. The upper (tetrahydro)furan unit in 10 is a succinic anhydride, a reactive moiety not often found 
in plants but presumably stable in the arid climate in which T. yemense grows in nature. Compound 13 results 
from a relatively unusual ring-contracting skeletal rearrangement during biosynthesis. Interestingly, 7–10 were 
found to enhance the glucose-triggered release of insulin from isolated murine pancreatic islets to a greater extent 
than the standard anti-diabetic drug tolbutamide; these compounds represent new leads for the development 
of treatments for this widespread disease.
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